Association of anthropometric parameters as a risk factor for development of diabetic retinopathy in patients with diabetes mellitus (original) (raw)

References

  1. Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366:1227–39.
    Article CAS Google Scholar
  2. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pr. 2014;103:137–49.
    Article CAS Google Scholar
  3. Trento M, Passera P, Trevisan M, Schellino F, Sitia E, Albani S, et al. Quality of life, impaired vision and social role in people with diabetes: a multicenter observational study. Acta Diabetol. 2013;50:873–7.
    Article Google Scholar
  4. Klein R, Klein BE. Blood pressure control and diabetic retinopathy. Br J Ophthalmol. 2002;86:365–7.
    Article CAS Google Scholar
  5. Beulens JWJ, Patel A, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, et al. Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Diabetologia. 2009;52:2027–36.
    Article CAS Google Scholar
  6. Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376:419–30.
    Article Google Scholar
  7. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992;15:815–9.
    Article CAS Google Scholar
  8. Turner R, Cull C, Holman R. United Kingdom prospective diabetes study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med. 1996;124:136–45.
    Article CAS Google Scholar
  9. Dirani M, Xie J, Fenwick E, Benarous R, Rees G, Wong TY, et al. Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. Invest Ophthalmol Vis Sci. 2011;52:4416–21.
    Article Google Scholar
  10. Guasch-Ferre M, Bullo M, Martinez-Gonzalez MÁ, Corella D, Estruch R, Covas MI, et al. Waist-to-height ratio and cardiovascular risk factors in elderly individuals at high cardiovascular risk. PLoS ONE. 2012;7:e43275.
    Article CAS Google Scholar
  11. Lundgren H, Bengtsson C, Blohme G, Lapidus L, Sjostrom L. Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: results from a prospective population study in Gothenburg, Sweden. Int J Obes. 1989;13:413–23.
    CAS Google Scholar
  12. Warne DK, Charles MA, Hanson RL, Jacobsson LTH, McCance DR, Knowler WC, et al. Comparison of body size measurements as predictors of NIDDM in Pima Indians. Diabetes Care. 1995;18:435–9.
    Article CAS Google Scholar
  13. Tulloch-Reid MK, Williams DE, Looker HC, Hanson RL, Knowler WC. Do measures of body fat distribution provide information on the risk of type 2 diabetes in addition to measures of general obesity? Comparison of anthropometric predictors of type 2 diabetes in Pima Indians. Diabetes Care. 2003;26:2556–61.
    Article Google Scholar
  14. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr. 2005;81:555–63.
    Article CAS Google Scholar
  15. Nuttall FQ. Body mass index: obesity, BMI, and health: a critical review. Nutr Today. 2015;50:117–28.
    Article Google Scholar
  16. Deepa M, Farooq S, Deepa R, Manjula D, Mohan V. Prevalence and significance of generalized and central body obesity in an urban Asian Indian population in Chennai, India (CURES: 47). Eur J Clin Nutr. 2009;63:259–67.
    Article CAS Google Scholar
  17. Smith SC Jr, Haslam D. Abdominal obesity, waist circumference and cardio-metabolic risk: awareness among primary care physicians, the general population and patients at risk-the Shape of the Nations survey. Curr Med Res Opin. 2007;23:29–47.
    Article Google Scholar
  18. Terry RB, Stefanick ML, Haskell WL, Wood PD. Contributions of regional adipose tissue depots to plasma lipoprotein concentrations in overweight men and women: possible protective effects of thigh fat. Metabolism. 1991;40:733–40.
    Article CAS Google Scholar
  19. Seidell JC, Pérusse L, Després JP, Bouchard C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study. Am J Clin Nutr. 2001;74:315–21.
    Article CAS Google Scholar
  20. Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC, Shaw JE. Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Int J Obes Relat Metab Disord. 2004;28:402–9.
    Article CAS Google Scholar
  21. Cho NH, Oh TJ, Kim KM, Choi SH, Lee JH, Park KS, et al. Neck circumference and incidence of diabetes mellitus over 10 years in the Korean Genome and Epidemiology Study (KoGES). Sci Rep. 2015;5:18565.
    Article CAS Google Scholar
  22. Zhu Y, Lin Q, Zhang Y, Deng H, Hu X, Yang X, et al. Mid-upper arm circumference as a simple tool for identifying central obesity and insulin resistance in type 2 diabetes. PLoS ONE. 2020;15:e0231308.
    Article CAS Google Scholar
  23. Katusić D, Tomić M, Jukić T, Kordić R, Sikić J, Vukojević N, et al. Obesity-a risk factor for diabetic retinopathy in type 2 diabetes? Coll Antropol. 2005;29(Suppl 1):47–50.
    Google Scholar
  24. Zhang L, Krzentowski G, Albert A, Lefebvre PJ. Risk of developing retinopathy in diabetes control and complications trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care. 2001;24:1275–9.
    Article CAS Google Scholar
  25. Li X, Wang Z. Prevalence and incidence of retinopathy in elderly diabetic patients receiving early diagnosis and treatment. Exp Ther Med. 2013;5:1393–6.
    Article Google Scholar
  26. De Block CE, De Leeuw IH, Van, Gaal LF. Impact of overweight on chronic microvascular complications in type 1 diabetic patients. Diabetes Care. 2005;28:1649–55.
    Article Google Scholar
  27. Klein R, Klein BE, Moss SE. Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med. 1997;157:650–6.
    Article CAS Google Scholar
  28. Lim LS, Tai ES, Mitchell P, Wang JJ, Tay WT, Lamoureux E, et al. C-reactive protein, body mass index, and diabetic retinopathy. Invest Ophthalmol Vis Sci. 2010;51:4458–63.
    Article Google Scholar
  29. Raman R, Rani PK, Gnanamoorthy P, Sudhir RR, Kumaramanikavel G, Sharma T. Association of obesity with diabetic retinopathy: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS Report no. 8). Acta Diabetol. 2010;47:209–15.
    Article Google Scholar
  30. Dowse GK, Humphrey ARG, Collins VR, Plehwe W, Gareeboo H, Fareed D, et al. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol. 1998;147:448–57.
    Article CAS Google Scholar
  31. Wang J, Heymsfield SB, Aulet M, Thornton JC, Pierson RN Jr. Body fat from body density: underwater weighing vs. dual-photon absorptiometry. Am J Physiol. 1989;256:E829–834.
    CAS Google Scholar
  32. Zhou JB, Yuan J, Tang XY, Zhao W, Luo FQ, Bai L, et al. Is central obesity associated with diabetic retinopathy in Chinese individuals? An exploratory study. J Int Med Res. 2019;47:5601–12.
    Article Google Scholar
  33. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999;84:137–44.
    CAS Google Scholar
  34. Fang H, Berg E, Cheng X, Shen W. How to best assess abdominal obesity. Curr Opin Clin Nutr Metab Care. 2018;21:360–5.
    Article Google Scholar
  35. Man REK, Sabanayagam C, Chiang PPC, Li LJ, Noonan JE, Wang JJ, et al. Differential association of generalized and abdominal obesity with diabetic retinopathy in Asian patients with type 2 diabetes. JAMA Ophthalmol. 2016;134:251–7.
    Article Google Scholar
  36. Pu YF, He HB, Zhao ZG, Chen J, Ni YX, Zhong J, et al. Evaluation of visceral adipose in abdominal obesity and its clinical application. Zhonghua Yi Xue Za Zhi. 2008;88:2391–4.
    Google Scholar
  37. Hwang IC, Bae JH, Kim JM. Relationship between body fat and diabetic retinopathy in patients with type 2 diabetes: a nationwide survey in Korea. Eye. 2019;33:980–7.
    Article CAS Google Scholar
  38. Sabanayagam C, Sultana R, Banu R, Rim T, Tham YC, Mohan S, et al. Association between body mass index and diabetic retinopathy in Asians: the Asian Eye Epidemiology Consortium (AEEC) study. Br J Ophthalmol. 2021. https://doi.org/10.1136/bjophthalmol-2020-318208.
  39. Rooney D, Lye WK, Tan G, Lamoureux EL, Ikram MK, Cheng CY, et al. Body mass index and retinopathy in Asian populations with diabetes mellitus. Acta Diabetol. 2015;52:73–80.
    Article Google Scholar
  40. Rajalakshmi R, Amutha A, Ranjani H, Ali MK, Unnikrishnan R, Anjana RM, et al. Prevalence and risk factors for diabetic retinopathy in Asian Indians with young onset type 1 and type 2 diabetes. J Diabetes Complications. 2014;28:291–7.
    Article Google Scholar
  41. Sen D, Ghosh S, Roy D. Correlation of C-reactive protein and body mass index with diabetic retinopathy in Indian population. Diabetes Metab Syndr. 2015;9:28–9.
    Article Google Scholar
  42. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2019. American Diabetes Association. Diabetes Care. 2019;42(Suppl 1):S13–28.
    Google Scholar
  43. World Health Organization. Measuring obesity—classification and description of anthropometric data. Report on a WHO consultation of the epidemiology of obesity. Warsaw 21–23 October 1987. Copenhagen: WHO; 1989. (Nutrition Unit document, EUR/ICP/NUT 123).
  44. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Diabetes prevention program research group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
    Article CAS Google Scholar
  45. Bays HE, Chapman RH, Grandy S, SHIELD Investigators’ Group. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pr. 2007;61:737–47.
    Article CAS Google Scholar
  46. Gray N, Picone G, Sloan F, Yashkin A. Relation between BMI and diabetes mellitus and its complications among US older adults. South Med J. 2015;108:29–36.
    Article Google Scholar
  47. Maskarinec G, Grandinetti A, Matsuura G, Sharma S, Mau M, Henderson BE, et al. Diabetes prevalence and body mass index differ by ethnicity: the multiethnic cohort. Ethn Dis. 2009;19:49–55.
    Google Scholar
  48. Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care. 2007;30:1562–6.
    Article CAS Google Scholar
  49. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes. 1998;47:699–713.
    Article CAS Google Scholar
  50. Kim ES, Jeong JS, Han K, Kim MK, Lee SH, Park YM, et al. Impact of weight changes on the incidence of diabetes mellitus: a Korean nationwide cohort study. Sci Rep. 2018;8:3735.
    Article Google Scholar
  51. Kim JA, Kim DH, Kim SM, Park YG, Kim NH, Baik SH, et al. Impact of the dynamic change of metabolic health status on the incident type 2 diabetes: a nationwide population-based cohort study. Endocrinol Metab. 2019;34:406–14.
    Article CAS Google Scholar
  52. Preis SR, Massaro JM, Hoffmann U, D'Agostino RB, Levy D, Robins SJ, et al. Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. J Clin Endocrinol Metab. 2010;95:3701–10.
    Article CAS Google Scholar
  53. Afarid M, Attarzadeh A, Farvardin M, Ashraf H. The association of serum leptin level and anthropometric measures with the severity of diabetic retinopathy in type 2 diabetes mellitus. Med Hypothesis Disco Innov Ophthalmol. 2018;7:156–62.
    Google Scholar
  54. Feller S, Boeing H, Pischon T. Body mass index, waist circumference, and the risk of type 2 diabetes mellitus: implications for routine clinical practice. Dtsch Arztebl Int. 2010;107:470–6.
    Google Scholar
  55. Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, Kostense PJ, et al. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr. 2003;77:1192–7.
    Article CAS Google Scholar
  56. Jung KJ, Kimm H, Yun JE, Jee SH. Thigh circumference and diabetes: obesity as a potential effect modifier. J Epidemiol. 2013;23:329–36.
    Article Google Scholar
  57. Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol. 2020;16:177–89.
    Article Google Scholar
  58. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, et al. Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. Diabetes Care. 2002;25:1320–5.
    Article Google Scholar
  59. Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med J Br Diabet Assoc. 2007;24:137–44.
    Article Google Scholar
  60. Looker HC, Nyangoma SO, Cromie D, Olson JA, Leese GP, Black M, et al. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia. 2012;55:2335–42.
    Article CAS Google Scholar
  61. Goldberg IJ. Clinical review 124: diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab. 2001;86:965–71.
    Article CAS Google Scholar
  62. Davidson RA, Travis MT, Bernier RM. Bruns-Garland syndrome (diabetic amyotrophy). Orthopedics. 2003;26:87–8.
    Article Google Scholar
  63. Sasongko MB, Widyaputri F, Sulistyoningrum DC, Wardhana FS, Widayanti TW, Supanji S, et al. Estimated resting metabolic rate and body composition measures are strongly associated with diabetic retinopathy in Indonesian adults with type 2 diabetes. Diabetes Care. 2018;41:2377–84.
    Article Google Scholar

Download references